Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ocular myasthenia gravis.

Rachael D Elrod¹, David A Weinberg

¹Department of Neuro-Ophthalmology and Ophthalmic Plastic Surgery, Division of Ophthalmology, University of Vermont College of Medicine, Burlington, VT 05401, USA.

Ophthalmology Clinics of North America

|September 1, 2004

Summary

Ocular myasthenia gravis, affecting the eyes, can lead to vision problems. Immunomodulatory treatments, like corticosteroids, are often effective and may prevent generalization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rare fibroadenoma of the right upper eyelid arising from the tarsal plate.

Orbit (Amsterdam, Netherlands)·2026

Same author

Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2024

Same author

Thyroid eye disease with choroidal folds.

Orbit (Amsterdam, Netherlands)·2020

Same author

Ophthalmic Plastic Surgery in Patients 100 Years and Older.

Ophthalmic plastic and reconstructive surgery·2018

Same author

Effects of erythropoietin stimulating agent (ESA) automated adjustment protocols on hemoglobin levels and mortality in end stage renal disease patients.

Medicine and health, Rhode Island·2012

Same author

Preoperative assessment of the eye and periocular region.

Seminars in plastic surgery·2010

Area of Science:

Neurology
Ophthalmology

Background:

Myasthenia gravis can be confined to the eyes (ocular myasthenia) or affect the whole body (generalized myasthenia).
Ocular myasthenia often presents with blepharoptosis or ophthalmoparesis, causing diplopia, but motility disorders vary.
Diagnosis relies on identifying fatigable muscle weakness through patient history and examination.

Purpose of the Study:

To review the diagnosis and management of ocular myasthenia gravis.
To highlight the effectiveness of immunomodulatory therapies in ocular myasthenia.

Main Methods:

Review of clinical presentation and diagnostic methods for ocular myasthenia.
Evaluation of therapeutic responses, including acetylcholinesterase inhibitors and immunomodulatory treatments.
Discussion of the ice test as a diagnostic tool.

Main Results:

The ice test is increasingly used for diagnosing ocular myasthenia, replacing the edrophonium (Tensilon) test.
Many patients with ocular myasthenia show limited improvement with acetylcholinesterase inhibitors alone.
Immunomodulatory treatments, particularly systemic corticosteroids, are frequently effective.

Conclusions:

Ocular myasthenia diagnosis involves recognizing fatigable weakness and specific ocular signs.
Acetylcholinesterase inhibitors may be insufficient for ocular myasthenia treatment.
Immunomodulatory therapy is a key treatment, potentially preventing the progression to generalized myasthenia gravis.

Related Experiment Videos